Biosound begins shipping AU5 in U.S.

Article

Biosound Esaote of Indianapolis has begun U.S. shipments of AU5, the company’s newest color-flow ultrasound scanner. AU5 was cleared by the Food and Drug Administration in August and is targeted at general imaging, vascular, intraoperative, ob/gyn,

Biosound Esaote of Indianapolis has begun U.S. shipments of AU5, the company’s newest color-flow ultrasound scanner. AU5 was cleared by the Food and Drug Administration in August and is targeted at general imaging, vascular, intraoperative, ob/gyn, and intracavity applications. Esaote has shipped about 400 AU5 units internationally.

Highlights on the scanner include Digital Storage Module, which adds archiving capabilities and support for the DICOM standard. Working in conjunction with DSM is the company’s ImageLab software, which turns a PC into an off-line image review workstation.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.